WINDTREE THERAPEUTICS INC /DE/ Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2016-03-29
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-09-30 was 0.00 shares.
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2014-09-30 was 0.00 shares.
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2014-06-30 was 821.00K shares, a 12.31% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2015 was 0.00 shares, a 100.00% decline from fiscal 2014.
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2014 was 67.00K shares.
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 0.00 shares.
- WINDTREE THERAPEUTICS INC /DE/ incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | 0.00 shares 10-K · filed 2016-03-29 | ||||
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-05 | 0.00 shares 10-Q · filed 2015-11-05 | |||
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-10 | 0.00 shares 10-Q · filed 2015-08-10 | |||
| 2014-12-31 | 67.00K shares 10-K · filed 2016-03-29 | 930.00K shares 10-K · filed 2015-03-16 | |||
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-05 | 1.12M shares 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | 821.00K shares 10-Q · filed 2015-08-10 | 1.34M shares 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-16 | ||||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-07 | 1.14M shares 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | 731.00K shares 10-Q · filed 2014-08-07 | 1.36M shares 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | 0.00 shares 10-Q · filed 2013-11-12 | 0.00 shares 10-Q · filed 2013-11-12 | |||
| 2012-06-30 | 0.00 shares 10-Q · filed 2013-08-08 | 0.00 shares 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |